Evidence map›Paper›PMID 31221870›Full record

ArticleBMJ open2019

Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial.

Ngai Wah Cheung, Julie Redfern, Aravinda Thiagalingam, Tien-Ming Hng, Sheikh Mohammed Shariful Islam, Rabbia Haider, Sonia Faruquie, Clara Chow, SupportMe investigators

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Strategies to improve smoking cessation rates in primary care.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ngai Wah CheungDiabetes & Endocrinology, University of Sydney, Westmead, New South Wales, Australia.
Julie RedfernWestmead Applied Research Centre, University of Sydney, Westmead, New South Wales, Australia.
Aravinda ThiagalingamWestmead Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Tien-Ming HngDiabetes & Endocrinology, Blacktown Mount Druitt Hospital, Blacktown, New South Wales, Australia.
Sheikh Mohammed Shariful IslamThe George Institute for Global Health, Sydney, New South Wales, Australia.ORCID 0000-0001-7926-9368
Rabbia HaiderDiabetes & Endocrinology, University of Sydney, Westmead, New South Wales, Australia.
Sonia FaruquieDiabetes & Endocrinology, University of Sydney, Westmead, New South Wales, Australia.
Clara ChowWestmead Applied Research Centre, University of Sydney, Westmead, New South Wales, Australia.
SupportMe investigators
The University of Sydney · AUBlacktown & Mount Druitt Hospital · AUThe George Institute for Global Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLow-cost interventions providing self-management support are needed for people with coronary artery disease (CAD) and diabetes. Mobile phone text messaging provides a potential vehicle for this. The SupportMe Trial aims to assess the feasibility of embedding a text messaging programme into routine clinical practice and will determine if this improves cardiovascular risk factor and diabetes control among patients with CAD or type 2 diabetes. METHODS AND ANALYSIS: SupportMe is a randomised controlled trial to be conducted within the framework of a health district-wide integrated care programme for people with CAD or type 2 diabetes mellitus. One thousand subjects will be recruited, with at least 500 in each group. Intervention subjects will receive four text messages a week for 6 months, which provide advice, motivation, information and support for disease management and healthy behaviour. The primary outcome is systolic blood pressure at 6 months. Secondary outcomes include body mass index, waist circumference, low-density lipoprotein cholesterol, physical activity levels, dietary intake, quality of life, mood and smoking cessation, and for subjects with diabetes, glycosylated haemoglobin and fasting serum glucose. A process and economic evaluation will also be conducted. ETHICS AND DISSEMINATION: The study has been approved by the Western Sydney Local Health District Human Research Ethics Committee (AU RED HREC/16/WMEAD/331). Results will be disseminated via the scientific forums including peer-reviewed publications and presentations at national and international conferences. TRIAL REGISTRATION NUMBER: ACTRN12616001689460.

Indexed as

Self-ManagementText MessagingBlood PressureCholesterol, LDLCoronary Artery DiseaseDiabetes Mellitus, Type 2ExerciseGlycated HemoglobinHealth BehaviorHumansLife StyleMedication AdherenceMotivationPragmatic Clinical Trials as TopicQuality of LifeReminder SystemsCholesterol, LDLGlycated Hemoglobinclinical trialscoronary heart diseasegeneral diabetestelemedicine

Identifiers

PMID31221870
PMCPMC6589039
OpenAlexW2949612371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.